Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 18/20 | 0.65 |
| ▸ | BTK | Q06187 | 2/20 | 0.56 |
| ▸ | HPGDS | O60760 | 2/20 | 0.55 |
| ▸ | DDB1 | Q16531 | 12/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22661369 | 1.00 | CRBN (0.65) | CRBNBTKHPGDSDDB1ALDH1A1 | |
| SCHEMBL22645447 | 0.92 | CRBN (0.55) | CRBNBTKHPGDSDDB1 | |
| SCHEMBL25196629 | 0.88 | CRBN (0.61) | CRBNBTKHPGDSDDB1ALDH1A1 | |
| SCHEMBL24734963 | 0.87 | CRBN (0.58) | CRBNBTKHPGDSDDB1 | |
| SCHEMBL29841399 | 0.87 | CRBN (0.58) | CRBNBTKHPGDSDDB1 | |
| SCHEMBL29494178 | 0.87 | CRBN (0.58) | CRBNBTKHPGDSDDB1 | |
| SCHEMBL30312979 | 0.87 | CRBN (0.65) | CRBNBTKHPGDSDDB1ALDH1A1 | |
| SCHEMBL29841499 | 0.87 | CRBN (0.60) | CRBNBTKHPGDSDDB1ALDH1A1 | |
| SCHEMBL27203779 | 0.87 | CRBN (0.60) | CRBNBTKHPGDSDDB1ALDH1A1 | |
| SCHEMBL23129189 | 0.86 | CRBN (0.49) | CRBNBTKHPGDSDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4146660-A1 | BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF | Nurix Therapeutics, Inc. (US) | 2023-03-15 | — | — | EP | disclosed |